IEQ Capital’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,671
Closed -$86.5K – 2170
2026
Q2
$86.5K Sell
10,671
-4,230
-28% -$31K ﹤0.01% 1956
2026
Q1
$95.2K Buy
14,901
+3,406
+30% +$22K ﹤0.01% 1802
2025
Q4
$68.4K Buy
+11,495
New +$61K ﹤0.01% 1792
2025
Q3
– Sell
-14,305
Closed -$49.1K – 2019
2025
Q2
$49.1K Buy
+14,305
New +$45.7K ﹤0.01% 1765

Other funds holding PBYI

IEQ Capital's PBYI Position: Q3 2026 in Review

IEQ Capital sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 10,671 shares — an estimated $86.5K sold.

IEQ Capital first reported a position in PBYI in Q2 2025 and held it in 4 quarters. The position peaked at $95.2K in Q1 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • IEQ Capital reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
  • IEQ Capital sold 10,671 Puma Biotechnology shares in Q3 2026, an estimated $86.5K.
  • IEQ Capital first reported a position in Puma Biotechnology in Q2 2025 and held it in 4 quarters.
  • IEQ Capital's Puma Biotechnology position peaked at $95.2K in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.